医疗保健分析市场 - 全球产业规模、份额、趋势、机会和预测：按组件、部署模式、类型、应用、最终用户、地区和竞争格局划分，2021-2031 年

全球医疗保健分析市场预计将从2025年的493.3亿美元显着成长至2031年的1,949.6亿美元，复合年增长率（CAGR）将达到25.74%。该市场依赖系统性地运用计算分析、统计建模和数据聚合技术，以提取可操作的洞察，从而推动营运、财务和临床方面的改进。推动这一成长的关键因素包括降低不断上涨的医疗保健成本的迫切需求，以及整个行业向基于价值的医疗模式的转变，后者需要对患者疗效进行精确衡量。此外，医疗记录的广泛数位化正在建立必要的底层基础设施，从而部署强大的分析工具，以改善医疗服务提供者的决策并优化资源分配。

儘管取得了这些进展，但与资料互通性和严格的隐私法规相关的重大障碍仍然阻碍着不同系统之间敏感资讯的顺畅交换。然而，随着医疗机构寻求利用技术简化临床和行政运营，先进数据工具的采用率正在加速成长。美国医学会 (AMA) 2024 年的一项调查发现，66% 的医生表示目前在实践中使用人工智慧工具，较前一年的 38% 显着增长。这项数据凸显了医疗保健领域对先进分析能力的快速应用。

市场驱动因素

人工智慧 (AI) 与巨量资料融合是全球医疗分析市场的关键驱动力，从根本上改变了医疗机构提升营运效率和提供临床决策支援的方式。借助复杂的数据集，医疗机构现在可以利用预测模型更准确地预测患者预后并分配资源。在应对日益增长的数据量需求的推动下，这项技术正迅速从理论试点阶段迈向实际应用阶段。根据医疗集团管理协会 (MGMA) 于 2024 年 10 月进行的一项调查，43% 的医疗集团表示今年将采用或扩大人工智慧的应用，这标誌着医疗行业正朝着利用自动化智慧处理复杂医疗资讯的方向迈出坚实的一步。

同时，基于云端的分析解决方案的蓬勃发展为这些先进功能奠定了基础。传统的本地部署系统正迅速被敏捷的云端平台所取代，这些平台能够实现无缝的互通性和资料交换，这对人口健康管理至关重要。经营团队正优先考虑这种现代化转型，以建立能够满足未来分析需求的强大数据系统。根据Hackoda于2024年3月发布的《2024年医疗保健数据现状报告》，74%的医疗机构计划在未来两年内将资料集中迁移到云端平台，这显示医疗产业正在发生显着的结构性转变。持续的资本投资进一步推动了这一发展势头。根据Rock Health的数据显示，光是2024年上半年，美国数位医疗Start-Ups就透过266笔交易筹集了57亿美元，凸显了该市场的雄厚财力。

市场挑战

全球医疗保健分析市场扩张面临的主要障碍之一是资料互通性持续不足以及严格的隐私法规。该行业产生大量的健康讯息，但专有标准和不相容的软体系统往往将这些数据孤立地储存在各自独立的系统中。为了使分析能够提供准确的预测模型和可操作的洞察，演算法必须能够存取全面、纵向的患者记录。当数据无法在不同的财务和临床系统之间无缝流动时，最终得到的数据集往往不完整或不一致，从而削弱分析结果的可靠性，并降低医疗服务提供者对数据驱动策略的信心。

此外，应对复杂的合规环境和弥合技术差距所需的营运资源给机构预算带来了巨大压力。医疗机构往往被迫将资金用于监管合规和人工数据核对，而不是投资先进的分析能力。这种行政负担十分沉重；2024 年医疗集团管理协会 (MGMA) 的一项调查发现，89% 的医疗机构领导者表示，过去 12 个月中，其机构的监管负担总体有所增加。非临床工作的增加直接限制了可用于实施强大分析解决方案的财务资源，从而有效地减缓了市场成长。

市场趋势

生命科学领域真实世界数据（RWE）分析的蓬勃发展正在改变监管路径和药物研发。製药公司越来越多地利用分析患者登记数据和电子健康记录的方法来补充临床试验。这一趋势使得药物疗效的快速检验成为可能，并透过分析非受控环境下不同人群的数据，加速上市后监测。这种数据整合的规模庞大，对支持监管决策至关重要。根据欧洲药品管理局（EMA）于2024年3月发布的《数据分析与真实世界研究网络（DARWIN EU）报告》，该网络已扩展其访问欧洲约1.3亿患者数据的能力，使相关人员能够在即时环境中产生关于药物疗效的可靠证据。

此外，远端监测资料流与穿戴式物联网的整合正在推动对能够处理高频患者产生健康数据的分析技术的需求。医疗服务提供者正从间歇性护理转向持续监测，这就需要能够解读生理数据并检测早期预警讯号的演算法。这种整合使临床医生能够主动干预，从而减少患者再次入院，并改善患者的长期预后。随着预测医学价值的日益凸显，这类监测能力的投资正在加速成长。根据皇家飞利浦于2024年6月发布的《2024年未来健康指数》报告，40%的医疗保健领导者计划在未来三年内将远端患者监护扩展到远距中风护理，这凸显了预测分析在患者照护现代化中的重要性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球医疗保健分析市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按组件（硬体、软体、服务（软体服务、商业分析服务））
  • 依部署类型（本机部署、云端部署）
  • 按类型（预测分析、指示性分析、说明分析）
  • 按应用领域（财务分析、营运与管理分析、临床分析、人口健康分析）
  • 依最终用户（医疗支付者、医疗服务提供者、生命科学公司）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美医疗保健分析市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

7. 欧洲医疗保健分析市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区医疗保健分析市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲医疗保健分析市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲医疗保健分析市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球医疗保健分析市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Digital Reasoning Systems Inc.
• International Business Machines Corporation（IBM）
• Information Builders Inc.
• Allscripts Healthcare Solutions, Inc.
• IQVIA Holdings Inc.
• 3M Company
• McKesson Corporation
• MedeAnalytics Inc.
• Optum Inc.
• Cerner Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Healthcare Analytics Market is projected to experience substantial growth, rising from USD 49.33 Billion in 2025 to USD 194.96 Billion by 2031, representing a CAGR of 25.74%. This market involves the systematic use of computational analysis, statistical modeling, and data aggregation to extract actionable insights that drive improvements in operational, financial, and clinical areas. Key factors fueling this expansion include the urgent need to reduce rising healthcare costs and the industry-wide shift toward value-based care models, which require accurate measurement of patient outcomes. Additionally, the extensive digitization of medical records creates the foundational infrastructure needed to implement robust analytical tools that refine provider decision-making and optimize resource allocation.

Despite this progress, significant hurdles regarding data interoperability and strict privacy regulations continue to obstruct the smooth exchange of sensitive information across different systems. However, adoption rates for advanced data tools are accelerating among providers aiming to utilize technology for greater clinical and administrative efficiency. According to the American Medical Association in 2024, 66% of physicians reported currently using artificial intelligence tools in their practice, a notable increase from 38% the previous year. This statistic highlights the rapid incorporation of sophisticated analytical capabilities within the healthcare sector.

Market Driver

The convergence of Artificial Intelligence (AI) and Big Data acts as a major catalyst for the Global Healthcare Analytics Market, fundamentally transforming how providers handle operational efficiency and clinical decision support. By utilizing complex datasets, healthcare institutions can now employ predictive modeling to forecast patient outcomes and allocate resources with high precision. This technological evolution is swiftly moving from theoretical pilots to practical application, driven by the necessity to manage growing volumes of data. According to the Medical Group Management Association (MGMA) in an October 2024 poll, 43% of medical groups reported adding or expanding their use of AI this year, demonstrating a tangible industry shift toward automated intelligence for handling complex medical information.

At the same time, the growth of cloud-based analytics solutions is providing the essential infrastructure needed to support these advanced capabilities. Legacy on-premise systems are increasingly being replaced by agile cloud platforms that facilitate seamless interoperability and data exchange, which are vital for population health management. Leadership teams are prioritizing this modernization to ensure their data systems are robust enough for future analytics needs. According to Hakkoda's 'Healthcare State of Data 2024' report from March 2024, 74% of healthcare organizations intend to centralize on a cloud platform within the next two years, indicating a significant structural migration. This momentum is further supported by sustained capital investment; according to Rock Health, U.S. digital health startups raised $5.7 billion across 266 deals in the first half of 2024 alone, highlighting the market's financial strength.

Market Challenge

A primary obstacle to the expansion of the Global Healthcare Analytics Market is the persistent lack of data interoperability combined with rigorous privacy regulations. Although the sector produces vast amounts of health information, this data often remains isolated in fragmented silos due to proprietary standards and incompatible software systems. For analytics to provide accurate predictive modeling and actionable insights, algorithms must have access to comprehensive, longitudinal patient records. When data cannot flow seamlessly between disparate financial and clinical systems, the resulting datasets are frequent incomplete or inconsistent, which undermines the reliability of analytical outputs and reduces provider confidence in data-driven strategies.

Moreover, the operational resources needed to navigate these complex compliance landscapes and bridge technical gaps significantly deplete organizational budgets. Instead of investing in advanced analytical capabilities, healthcare entities are often forced to divert capital toward regulatory adherence and manual data reconciliation. This administrative burden is substantial; according to the Medical Group Management Association in 2024, 89% of medical practice leaders reported that the overall regulatory burden on their practice had increased over the past 12 months. This rise in non-clinical workload directly limits the financial resources available for adopting robust analytics solutions, effectively slowing market growth.

Market Trends

The growth of Real-World Evidence (RWE) analytics in life sciences is reshaping regulatory pathways and drug development. Pharmaceutical companies are increasingly using analytics to process data from patient registries and electronic health records to supplement clinical trials. This trend enables faster validation of drug efficacy and accelerates post-market surveillance by analyzing diverse populations outside of controlled environments. The scale of this data integration is massive and crucial for supporting regulatory decisions. According to the European Medicines Agency's 'Data Analysis and Real-World Interrogation Network (DARWIN EU)' report from March 2024, the network expanded its capacity to deliver real-world evidence by accessing data from approximately 130 million patients across Europe, enabling stakeholders to generate robust evidence on medicine effectiveness in real-time settings.

Furthermore, the convergence of remote monitoring data streams and wearable IoT is driving demand for analytics capable of processing high-frequency patient-generated health data. Healthcare providers are shifting from episodic care to continuous monitoring, necessitating algorithms that can interpret physiological data to detect early warning signs. This integration empowers clinicians to intervene proactively, thereby reducing hospital readmissions and improving long-term patient outcomes. Investment in these monitoring capabilities is accelerating as organizations recognize the value of predictive care. According to the Royal Philips 'Future Health Index 2024' report from June 2024, 40% of healthcare leaders indicated plans to expand remote patient monitoring into telestroke care within the next three years, highlighting the critical role of predictive analytics in modernizing patient care delivery.

Key Market Players

• Digital Reasoning Systems Inc.
• International Business Machines Corporation (IBM)
• Information Builders Inc.
• Allscripts Healthcare Solutions, Inc.
• IQVIA Holdings Inc.
• 3M Company
• McKesson Corporation
• MedeAnalytics Inc.
• Optum Inc.
• Cerner Corporation

Report Scope

In this report, the Global Healthcare Analytics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Healthcare Analytics Market, By Component

• Hardware
• Software
• Service (Software Service & Business Analytics Service)

Healthcare Analytics Market, By Deployment Mode

• On-Premises
• Cloud

Healthcare Analytics Market, By Type

• Predictive Analytics
• Prescriptive Analytics
• Descriptive Analytics

Healthcare Analytics Market, By Application

• Financial Analysis
• Operational & Administrative Analysis
• Clinical Analysis
• Population Health Analysis

Healthcare Analytics Market, By End User

• Healthcare Payers
• Healthcare Providers
• Life Science Companies

Healthcare Analytics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Analytics Market.

Available Customizations:

Global Healthcare Analytics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Healthcare Analytics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Hardware, Software, Service (Software Service, & Business Analytics Service))
  • 5.2.2. By Deployment Mode (On-Premises, Cloud)
  • 5.2.3. By Type (Predictive Analytics, Prescriptive Analytics, Descriptive Analytics)
  • 5.2.4. By Application (Financial Analysis, Operational & Administrative Analysis, Clinical Analysis, Population Health Analysis)
  • 5.2.5. By End User (Healthcare Payers, Healthcare Providers, Life Science Companies)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Healthcare Analytics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Deployment Mode
  • 6.2.3. By Type
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Healthcare Analytics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Deployment Mode
      • 6.3.1.2.3. By Type
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Healthcare Analytics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Deployment Mode
      • 6.3.2.2.3. By Type
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Healthcare Analytics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Deployment Mode
      • 6.3.3.2.3. By Type
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Healthcare Analytics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Deployment Mode
  • 7.2.3. By Type
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Healthcare Analytics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Deployment Mode
      • 7.3.1.2.3. By Type
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Healthcare Analytics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Deployment Mode
      • 7.3.2.2.3. By Type
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Healthcare Analytics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Deployment Mode
      • 7.3.3.2.3. By Type
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Healthcare Analytics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Deployment Mode
      • 7.3.4.2.3. By Type
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Healthcare Analytics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Deployment Mode
      • 7.3.5.2.3. By Type
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Healthcare Analytics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Deployment Mode
  • 8.2.3. By Type
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Healthcare Analytics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Deployment Mode
      • 8.3.1.2.3. By Type
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Healthcare Analytics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Deployment Mode
      • 8.3.2.2.3. By Type
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Healthcare Analytics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Deployment Mode
      • 8.3.3.2.3. By Type
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Healthcare Analytics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Deployment Mode
      • 8.3.4.2.3. By Type
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Healthcare Analytics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Deployment Mode
      • 8.3.5.2.3. By Type
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Healthcare Analytics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Deployment Mode
  • 9.2.3. By Type
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Healthcare Analytics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Deployment Mode
      • 9.3.1.2.3. By Type
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Healthcare Analytics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Deployment Mode
      • 9.3.2.2.3. By Type
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Healthcare Analytics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Deployment Mode
      • 9.3.3.2.3. By Type
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Healthcare Analytics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Deployment Mode
  • 10.2.3. By Type
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Healthcare Analytics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Deployment Mode
      • 10.3.1.2.3. By Type
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Healthcare Analytics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Deployment Mode
      • 10.3.2.2.3. By Type
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Healthcare Analytics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Deployment Mode
      • 10.3.3.2.3. By Type
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Healthcare Analytics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Digital Reasoning Systems Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. International Business Machines Corporation (IBM)
• 15.3. Information Builders Inc.
• 15.4. Allscripts Healthcare Solutions, Inc.
• 15.5. IQVIA Holdings Inc.
• 15.6. 3M Company
• 15.7. McKesson Corporation
• 15.8. MedeAnalytics Inc.
• 15.9. Optum Inc.
• 15.10. Cerner Corporation

16. Strategic Recommendations

17. About Us & Disclaimer